2026 Seattle Cellular Therapy Summit

Accreditation: 13.25 Nursing Contact Hours | 13.25 ABIM MOC II | 13.25 AMA PRA Category 1 Credit™ | 13.25 ACPE Pharmacy

Venue: Bell Harbor International Conference Center , 2211 Alaskan Way, Seattle, WA, United States

Start Date: Aug 14End Date: Aug 15, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

46+

Email if you have questions

Our Speakers

Planning Committee

Binay Shah, MD, MHA

Conference Director

Binayatara

Mazyar Shadman, MD

Conference Co-Chair

Fred Hutch Cancer Center/University of Washington

Faculty

Filippo Milano, MD

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Alexey Danilov, MD

Session Chair

City of Hope

Folashade Otegbeye, MPH, MBChB

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Nirav N Shah, MD

Session Chair

Medical College of Wisconsin

Rahul Banerjee, MD

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Jordan Gauthier, MD

Session Chair

Clinical Research Division, Fred Hutchinson Cancer Center

Mengyang Di, MD, PhD

Topic Presenter

University of Washington/Fred Hutch Cancer Center

Andrew Cowan, MD

Topic Presenter

BC Cancer Agency

Sid Devarakonda, MD

Topic Presenter

Lara E. Davis, MD

Topic Presenter

Fred Hutchinson Cancer Center

Max Julve, MD

Topic Presenter

Paolo Strati, MD

Topic Presenter

The University of Texas MD Anderson Cancer Center

Sibel Blau, MD

Topic Presenter

Northwest Medical Specialties, PLLC

Brian Hill, MD, PhD

Topic Presenter

Cleveland Clinic Foundation

Hitomi Hosoya, MD PhD

Topic Presenter

Yucai Wang, MD, PhD

Topic Presenter

Mayo clinic

Hira Shaikh, MD

Topic Presenter

University of Iowa

Ryan Cassaday, MD

Topic Presenter

University of Washington & Fred Hutch Cancer Center

Our Agenda

Day 1: Friday, August 14th, 2026

All timings are in Pacific Time (PDT, GMT-07:00) time.

08:00 AM - 09:15 AMRegistration, Breakfast, & Exhibits (Sound Room)

09:15 AM - 09:30 AMWelcome & Opening Remarks (Bay Auditorium)

09:30 AM - 09:45 AMBinaytara's Efforts in Improving Cancer Care Disparities (Non CME Accredited)- Dr. Binay Shah (Bay Auditorium)

09:45 AM - 11:15 AMSession 1 : Solid Tumors I (Bay Auditorium)

Session Chair: Lawrence Fong, MD

09:45 AM - 10:00 AM

Immuno-oncology for GU Malignancies – Lawrence Fong, MD

10:00 AM - 10:15 AM

Lung Cancer: Tarlatamab – Sid Devarakonda, MD

10:15 AM - 10:30 AM

Malignant Melanoma: Lifileucel and Beyond – Max Julve, MD

10:30 AM - 10:45 AM

Immunotherapy for Sarcoma – Lara E. Davis, MD

10:45 AM - 11:15 AM

Panel Discussion

Moderators:

Lawrence Fong, MD

Panelists:

Sid Devarakonda, MD; Max Julve, MD; Lara E. Davis, MD

11:15 AM - 12:15 PMSession 2 : Solid Tumors II (Bay Auditorium)

Session Chair: Folashade Otegbeye, MPH, MBChB

11:15 AM - 11:30 AM

Novel FOLR1 CAR-T Therapy – Soheil Meshinchi, MD

11:30 AM - 11:45 AM

FACT Standards for Immune Effector Cells in the Community Setting – Folashade Otegbeye, MPH, MBChB

11:45 AM - 12:15 PM

Panel Discussion

Moderators:

Folashade Otegbeye, MPH, MBChB

Panelists:

Soheil Meshinchi, MD

12:15 PM - 01:15 PMLunch & Exhibits (Sound)

01:15 PM - 02:30 PMSession 3 : CAR-T Cells — The Next Breakthroughs (Bay Auditorium)

Session Chair: Natalie Wuliji, DO

01:15 PM - 01:30 PM

Multispecific CAR-T — Will They Change Our Standard of Care? – Saurabh Dahiya, MD

01:30 PM - 01:45 PM

In-Vivo CAR-T Platforms – Hans-Peter Kiem, PhD

01:45 PM - 02:00 PM

CAR-T Therapy for Autoimmune Disorders – Natalie Wuliji, DO

02:00 PM - 02:30 PM

Panel Discussion

Moderators:

Natalie Wuliji, DO

Panelists:

Saurabh Dahiya, MD; Hans-Peter Kiem, PhD

02:30 PM - 02:45 PMBreak & Exhibits (Sound)

02:45 PM - 03:45 PMSession 4 : Leukemia and Transplant (Bay Auditorium)

Session Chair: Filippo Milano, MD

02:45 PM - 03:00 PM

Immunotherapy for Myeloid Malignancies — Challenges and Promises – Hany Elmariah, MD

03:00 PM - 03:15 PM

Cellular Therapy in Allogeneic Transplant (Orca-T, Omidubicel and Beyond) – Filippo Milano, MD

03:15 PM - 03:30 PM

ALL — Focus on Immunotherapeutic Approaches, Approved and Investigational Options – Ryan Cassaday, MD

03:30 PM - 03:45 PM

Panel Discussion

Moderators:

Filippo Milano, MD

Panelists:

Hany Elmariah, MD; Ryan Cassaday, MD

03:45 PM - 04:45 PMSession 5 : Chronic Lymphocytic Leukemia (Bay Auditorium)

Session Chair: Alexey Danilov, MD

03:45 PM - 04:00 PM

Immunotherapy (CAR-T and Bispecific Antibodies) for CLL – Bita Fakhri, MD, MPH

04:00 PM - 04:15 PM

How Will CLL Be Treated in 2030? – Alexey Danilov, MD

04:15 PM - 04:45 PM

Panel Discussion

Moderators:

Alexey Danilov, MD

Panelists:

Bita Fakhri, MD, MPH

Day 2: Saturday, August 15th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits (Sound Room)

08:00 AM - 09:30 AMSession 6 : Topics in T-Cell Engaging Therapies (Bay Auditorium)

Session Chair: Mazyar Shadman, MD

08:00 AM - 08:15 AM

Barriers to CAR-T Use — Challenges and Opportunities – Mazyar Shadman, MD

08:15 AM - 08:30 AM

Bispecific Antibodies in Community Setting — General Principles – Sibel Blau, MD

08:30 AM - 08:45 AM

Next-Generation T-Cell Engagers – Krish Patel, MD

08:45 AM - 09:00 AM

State of Cellular Immunotherapy in 2030 – Matthew Alexander Lunning, DO

09:00 AM - 09:30 AM

Panel Discussion

Moderators:

Mazyar Shadman, MD

Panelists:

Sibel Blau, MD; Krish Patel, MD; Matthew Alexander Lunning, DO

About 2026 Seattle Cellular Therapy Summit

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Our Agenda

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship